Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
701.54
587.43
494.27
543.93
485.35
319.13
179.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
701.54
587.43
494.27
543.93
485.35
319.13
179.11
Raw Material Cost
77.36
55.68
51.24
55.44
42.07
22.53
21.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
76.21
81.90
79.98
72.70
57.68
32.79
25.49
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.07
14.52
7.24
5.16
1.36
0.98
1.07
Selling and Distribution Expenses
448.42
375.30
312.50
352.46
295.77
220.56
149.41
Other Expenses
2.49
2.32
1.46
3.48
-0.94
0.65
1.49
Total Expenditure (Excl Depreciation)
641.93
550.61
465.52
520.55
387.46
283.37
212.09
Operating Profit (PBDIT) excl Other Income
59.6
36.800000000000004
28.700000000000003
23.4
97.89999999999999
35.8
-33
Other Income
14.06
15.39
19.22
34.22
14.71
9.16
5.95
Operating Profit (PBDIT)
90.03
72.83
56.81
77.53
133.23
55.05
-14.69
Interest
15.07
14.52
7.24
5.16
1.36
0.98
1.07
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
624.18
531.75
443.03
488.50
443.29
296.61
157.88
Depreciation
43.07
36.00
33.96
28.73
24.68
17.94
15.25
Profit Before Tax
31.89
22.30
15.62
43.65
107.19
36.13
-31.01
Tax
9.99
6.58
4.18
17.07
-0.77
0.00
0.03
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
22.26
20.76
17.56
26.58
107.96
36.13
-31.04
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
22.26
20.76
17.56
26.58
107.96
36.13
-31.04
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.36
-5.04
-6.11
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
21.90
15.72
11.44
26.58
107.96
36.13
-31.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
0.0
1.0
1.0
1.0
Reserves
903.68
924.68
916.91
881.63
844.66
376.97
340.84
Earnings per share (EPS)
0.05
0.05
0.04
0.07
0.27
0.09
-0.08
Diluted Earnings per share
0.05
0.05
0.04
0.07
0.27
0.09
-0.08
Operating Profit Margin (Excl OI)
4.69%
3.65%
0.74%
2.68%
19.33%
8.76%
-20.04%
Gross Profit Margin
10.68%
9.93%
10.03%
13.31%
27.17%
16.94%
-8.8%
PAT Margin
3.17%
3.53%
3.55%
4.89%
22.24%
11.32%
-17.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 19.42% vs 18.83% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 39.49% vs 37.72% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 32.40% vs 52.66% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 4.14% vs 101.39% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Chengdu Olymvax Biopharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
701.54
0
701.54
Other Operating Income
0.00
0.00
0.00
Total Operating income
701.54
0
701.54
Raw Material Cost
77.36
0
77.36
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
76.21
0
76.21
Power Cost
0
0
0.00
Manufacturing Expenses
15.07
0
15.07
Selling and Distribution Expenses
448.42
0
448.42
Other Expenses
2.49
0.00
2.49
Total Expenditure (Excl Depreciation)
641.93
0
641.93
Operating Profit (PBDIT) excl Other Income
59.61
0.00
59.61
Other Income
14.06
0
14.06
Operating Profit (PBDIT)
90.03
0
90.03
Interest
15.07
0
15.07
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
624.18
0
624.18
Depreciation
43.07
0
43.07
Profit Before Tax
31.89
0
31.89
Tax
9.99
0
9.99
Provisions and contingencies
0
0
0.00
Profit After Tax
22.26
0
22.26
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
22.26
0
22.26
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.36
0
-0.36
Other related items
0.00
0.00
0.00
Consolidated Net Profit
21.90
0
21.90
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
903.68
0
903.68
Earnings per share (EPS)
0.05
0
0.05
Diluted Earnings per share
0.05
0
0.05
Operating Profit Margin (Excl OI)
4.69%
0%
0.00
4.69%
Gross Profit Margin
10.68%
0%
0.00
10.68%
PAT Margin
3.17%
0%
0.00
3.17%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 70.15 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 19.42% vs 18.83% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 2.19 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 39.49% vs 37.72% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.60 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 32.40% vs 52.66% in Dec 2024
Annual - Interest
Interest 1.51 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 4.14% vs 101.39% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.69%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
